跳至主要内容
临床试验/ISRCTN17947655
ISRCTN17947655进行中(未招募)未知

Real-world performance evaluation of PreSize Neurovascular medical software in a clinical setting

Oxford Heartbeat Ltd0 个研究点目标入组 100 人开始时间: 2022年5月12日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adults aged 18 years or above
  • 2. Indicated to receive treatment for an intracranial aneurysm with one of the FDs compatible with PreSize Neurovascular at one of the participating NHS sites
  • 3. Able to receive both pre-operative 3D rotational angiography (3DRA) and post-operative 2D digital subtraction angiography (2DSA) or cone-beam computed tomography (CT), excluding allergy to iodinated contrast media

排除标准

  • 1. Any reasons in the opinion of the investigator, e.g. patient cases previously fitted with coiling in the same aneurysmal area might be deemed inappropriate for the purposes of this study if it significantly impacts the contrast in the pre-operative X-ray imaging
  • 2. Unable to give informed consent

研究者

发起方
Oxford Heartbeat Ltd

相似试验